Back to Journals » Clinical and Experimental Gastroenterology » Volume 6
The natural course of inflammatory bowel disease-indeterminate from childhood to adulthood: within a 25 year period
Authors Malaty HM, Mehta S, Abraham B, Garnett EA, Ferry GD
Received 2 March 2013
Accepted for publication 13 May 2013
Published 23 July 2013 Volume 2013:6 Pages 115—121
DOI https://doi.org/10.2147/CEG.S44700
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Hoda M Malaty,1 Seema Mehta,2,3 Bincy Abraham,1 Elizabeth A Garnett,4 George D Ferry2,3
1Department of Medicine, 2Department of Pediatrics, 3Texas Children’s Hospital, Baylor College of Medicine, Houston, Texas, USA; 4University of California, San Francisco, California, USA
Background: Inflammatory bowel disease (IBD)-indeterminate is a subgroup of IBD that has features of both ulcerative colitis (UC) and Crohn’s disease (CD).
Aims: To determine the clinical course of IBD-indeterminate in children over a 25 year period.
Methods: We performed a retrospective investigation on children diagnosed with IBD. Diagnosis and disease distribution of IBD was based on clinical, radiologic, endoscopic, and histologic examinations.
Results: Four hundred and twenty children diagnosed with IBD between 1986 and 2003 were identified from the IBD registry, 78 (22%) of whom were diagnosed with IBD-indeterminate. The mean age at diagnosis was 9.2 ± 4 years and the mean follow-up period was 4.1 ± 2 years. In 2003, 18 of 78 children (23%) were reclassified by the same physician based on the endoscopic and pathologic findings as follows: eight children with CD, five children with UC, and five children with non-IBD (eg, eosinophilic colitis). During 2011, 20 of the 60 patients who had maintained an IBD-indeterminate diagnosis were located and contacted, and detailed telephone interviews were conducted by the corresponding author. Two patients were reclassified as having CD (10%), one patient was reclassified as having eosinophilic colitis (5%), six patients remained with IBD-indeterminate (30%), and eleven patients (55%) reported a complete resolution of their symptoms. The follow-up period ranged from 10–18 years (mean 12.5 ± 3 years). Children who were reclassified as having CD were significantly younger than those who maintained an IBD-indeterminate diagnosis (6.4 ± 4 years versus11.2 ± 3 years, respectively, P = 0.05).
Conclusion: Children with IBD-indeterminate remain classified as IBD-indeterminate, or were clinically reclassified as CD or non-IBD, or became asymptomatic as they transitioned into adulthood. The need for IBD-indeterminate classification is of importance, especially when deciding on management and treatment.
Keywords: IBD-indeterminate, children, epidemiology, clinical course
© 2013 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.